Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-12

Clinical Trial Update: Melatonin Osteoporosis Prevention Study [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating melatonin for osteoporosis and osteopenia prevention has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Duquesne University | Conditions: Osteoporosis, Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2012-03-12